STERIS plc (NYSE:STE) Shares Sold by Cresset Asset Management LLC

Cresset Asset Management LLC lessened its holdings in STERIS plc (NYSE:STE - Free Report) by 71.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,745 shares of the medical equipment provider's stock after selling 6,962 shares during the period. Cresset Asset Management LLC's holdings in STERIS were worth $564,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of the business. Magnolia Capital Advisors LLC lifted its stake in shares of STERIS by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock valued at $521,000 after purchasing an additional 48 shares during the last quarter. Park Edge Advisors LLC lifted its stake in STERIS by 1.1% during the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock worth $958,000 after acquiring an additional 51 shares in the last quarter. Citizens Financial Group Inc. RI lifted its stake in STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock worth $201,000 after acquiring an additional 54 shares in the last quarter. Opal Wealth Advisors LLC lifted its stake in STERIS by 5.7% during the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock worth $230,000 after acquiring an additional 60 shares in the last quarter. Finally, Sage Private Wealth Group LLC lifted its stake in STERIS by 4.1% during the 4th quarter. Sage Private Wealth Group LLC now owns 1,537 shares of the medical equipment provider's stock worth $316,000 after acquiring an additional 61 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analyst Weigh In

STE has been the topic of several research reports. Stephens reissued an "overweight" rating and set a $250.00 target price on shares of STERIS in a research note on Thursday. JMP Securities increased their target price on STERIS from $265.00 to $280.00 and gave the stock a "market outperform" rating in a research note on Friday. Needham & Company LLC reissued a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Finally, Piper Sandler upped their price target on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, STERIS currently has an average rating of "Moderate Buy" and an average price target of $265.00.

STERIS Price Performance

Shares of STE traded up $5.24 during mid-day trading on Friday, hitting $252.12. The company's stock had a trading volume of 1,623,045 shares, compared to its average volume of 543,886. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a 50-day simple moving average of $224.13 and a 200 day simple moving average of $219.31. The firm has a market capitalization of $24.77 billion, a P/E ratio of 53.53 and a beta of 0.96. STERIS plc has a 1-year low of $200.98 and a 1-year high of $252.20.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.59 by $0.15. The firm had revenue of $1.48 billion during the quarter, compared to analysts' expectations of $1.47 billion. STERIS had a return on equity of 13.91% and a net margin of 8.66%. STERIS's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.58 earnings per share. Analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Investors of record on Tuesday, June 10th will be issued a dividend of $0.57 per share. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 annualized dividend and a yield of 0.90%. STERIS's dividend payout ratio is presently 36.77%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.